Variable DPP4 expression in multiciliated cells of the human nasal epithelium as a determinant for MERS-CoV tropism. [PDF]
Breugem TI +12 more
europepmc +1 more source
Harnessing immunotherapeutic molecules and diagnostic biomarkers as human-derived adjuvants for MERS-CoV vaccine development. [PDF]
Alrasheed AR +6 more
europepmc +1 more source
Design of an Epitope-Based Vaccine Against MERS-CoV. [PDF]
Almanaa TN.
europepmc +1 more source
Combination therapy enhances the antiviral activity of IFN-λ against SARS-CoV-2 and MERS-CoV. [PDF]
Zadeh VR +5 more
europepmc +1 more source
A 10 Year Long-Lived Cellular and Humoral MERS-CoV Immunity Cross-Recognizing the Wild-Type and Variants of SARS-CoV-2: A Potential One-Way MERS-CoV Cross-Protection Toward a Pan-Coronavirus Vaccine. [PDF]
Alosaimi B +9 more
europepmc +1 more source
Mucosal immunity in upper and lower respiratory tract to MERS-CoV. [PDF]
Shrwani KJ +14 more
europepmc +1 more source
Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV. [PDF]
Chao CW +25 more
europepmc +1 more source
Transmission dynamics of MERS-CoV in a transgenic human DPP4 mouse model. [PDF]
van Doremalen N +9 more
europepmc +1 more source
A single-dose intranasal immunization with a novel bat influenza A virus-vectored MERS vaccine provides effective protection against lethal MERS-CoV challenge. [PDF]
Shi L +11 more
europepmc +1 more source
Perturbation of <i>de novo</i> lipogenesis hinders MERS-CoV assembly and release, but not the biogenesis of viral replication organelles. [PDF]
Soultsioti M +6 more
europepmc +1 more source

